1. |
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002[J]. JAMA, 2006, 295(18):2164-2167.
|
2. |
How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer[J]. CMAJ, 2007, 177(11):1383-1384.
|
3. |
Yip L, Kelly L, Shuai Y, et al. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma[J]. Ann Surg Oncol, 2011, 18(7):2035-2041.
|
4. |
Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006, 9(3):189-198.
|
5. |
姚汝铖, 郑军, 邢荣春. 微小RNA在胰腺癌中的研究进展[J]. 中国普外基础与临床杂志, 2012, 19(8):911-915.
|
6. |
Lopez-Serra P, Esteller M. DNA methylation-associated silencingof tumor-suppressor microRNAs in cancer[J]. Oncogene, 2012, 31(13):1609-1622.
|
7. |
Mackiewicz M, Huppi K, Pitt JJ, et al. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA[J]. Breast Cancer Res Treat, 2011, 130(2):663-679.
|
8. |
Nalls D, Tang SN, Rodova M, et al. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells[J]. PLoS One, 2011, 6(8):e24099.
|
9. |
Gao LB, Li LJ, Pan XM, et al. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer[J]. Biol Chem, 2013, 394(3):415-420.
|
10. |
Vogt M, Munding J, Grüner M, et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas[J]. Virchows Arch, 2011, 458(3):313-322.
|
11. |
Hoque MO, Rosenbaum E, Westra WH, et al. Quantitative assessment of promoter methylation profiles in thyroid neoplasms[J]. J Clin Endocfinol Metab, 2005, 90(7):4011-4018.
|
12. |
Hiroki E, Suzuki F, Akahira J, et al. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma[J]. Int J Cancer, 2012, 131(4):E395-E404.
|
13. |
Wong KY, Yu L, Chim CS. DNA methylation of tumor suppressormiRNA genes:a lesson from the miR-34 family[J]. Epigenomics,.
|
14. |
Xing M, Cohen Y, Mambo E, et al. Early occurrence of RASSF1Ahypermethylation and its mutual exclusion with BRAF mutation inthyroid tumorigenesis[J]. Cancer Res, 2004, 64(5):1664-1668.
|
15. |
Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption ofcell-type-specific methylation at the maspin gene promoter is frequ-ently involved in undifferentiated thyroid cancers[J]. Oncogene,.
|
16. |
He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network[J]. Nature, 2007, 447(7148):1130-1134.
|
17. |
张明, 刘卫辉, 尤楠, 等. 7种microRNAs在原发性肝癌组织和癌旁组织间的差异表达及与血清肿瘤标志物水平的相关性研究[J]. 中国普外基础与临床杂志, 2010, 17(6):562-566.
|
18. |
Mathé E, Nguyen GH, Funamizu N, et al. Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide[J]. Int J Cancer, 2012, 131(3):760-765.
|
19. |
Yamazaki H, Chijiwa T, Inoue Y, et al. Overexpression of the miR-34 family suppresses invasive growth of malignant melanomawith the wild-type p53 gene[J]. Exp Ther Med, 2012, 3(5):793-796.
|
20. |
Benassi B, Flavin R, Marchionni L, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer[J]. Cancer Discov, 2012, 2(3):236-247.
|
21. |
Majid S, Dar AA, Saini S, et al. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways[J]. Clin Cancer Res, 2013, 19(1):73-84.
|
22. |
Du Y, Liu Z, Gu L, et al. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo[J]. BMC Cancer, 2012, 12:249.
|
23. |
Tsai KW, Wu CW, Hu LY, et al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer[J]. Int J Cancer, 2011, 129(11):2600-2610.
|
24. |
Balça-Silva J, Sousa Neves S, Gonçalves AC, et al. Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines[J]. Anticancer Res, 2012, 32(5):1603-1609.
|
25. |
Wang Z, Chen Z, Gao Y, et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer[J]. Cancer Biol Ther, 2011, 11(5):490-496.
|
26. |
, 23(5):1117-1124.
|
27. |
, 3(1):83-92.
|